Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis
Manasa Sagaram(University of Louisville), Vatsalya Vatsalya, Loretta Jophlin(University of Louisville), Wenke Feng(Mongolian University of Science and Technology), Charles F. Closson(University of Louisville), Maiying Kong(University of Louisville), Melanie L. Schwandt(National Institute on Alcohol Abuse and Alcoholism), Sally Condon(University of Louisville), Ashutosh Barve, Parthasarathy Ranganathan(Meenakshi Academy of Higher Education and Research)
Cited by 4
Related Papers
Copper Regulation of Hypoxia-Inducible Factor-1 Activity
|Molecular Pharmacology|2008|293
ACG Clinical Guideline: Alcohol-Associated Liver Disease
|The American Journal of Gastroenterology|2023|227
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
|Molecular Psychiatry|2018|127